Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease effects and associations.

Y Mitsuishi, J M Cecka

    Clinical Transplants
    |January 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Race significantly impacts kidney transplant outcomes, with differences in graft survival observed across racial groups and primary diseases. HLA tissue types and pre-transplant health also influence success rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Paul I. Terasaki, PhD, 1929-2016.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    HLA high-resolution typing for sensitized patients: a solution in search of a problem?

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Kidney paired donation in the presence of donor-specific antibodies.

    Kidney international·2013
    Same author

    Rapid improvement of osseous sarcoidosis after the treatment of pulmonary aspergillosis by itraconazole.

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2011
    Same author

    Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
    Same author

    Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Nephrology
    • Immunogenetics
    • Transplantation Medicine

    Background:

    • End-stage renal disease (ESRD) etiology varies significantly across racial groups, including White, Black, Hispanic, and Asian populations.
    • Racial disparities exist in the prevalence of diseases leading to ESRD, such as insulin-dependent diabetes mellitus (IDDM), hypertensive nephrosclerosis (NS), and chronic glomerulonephritis (CGN).
    • Understanding these demographic and etiological differences is crucial for analyzing kidney transplant outcomes.

    Purpose of the Study:

    • To investigate the influence of race, primary kidney disease, and human leukocyte antigen (HLA) tissue types on kidney transplant graft survival.
    • To identify specific HLA alleles associated with improved graft survival in different disease and racial cohorts.
    • To assess the impact of recipient age, sex, and pre-transplantation health status on transplant outcomes.

    Related Experiment Videos

    Main Methods:

    • Retrospective analysis of kidney transplant recipient and donor data, focusing on primary ESRD causes, race, HLA typing (specifically HLA-DR), and graft survival rates.
    • Statistical comparisons of graft survival rates across different racial groups, primary diseases, and HLA tissue types.
    • Evaluation of demographic factors (age, sex) and pre-transplant health status as predictors of transplant success.

    Main Results:

    • Race was a dominant factor in graft survival differences, more so than the primary disease, particularly among White recipients.
    • One-year graft survival varied by primary disease, with IgA nephropathy showing the highest rates and systemic lupus erythematosus (SLE) the lowest.
    • Specific HLA-DR types (e.g., HLA-DR3/4 in IDDM, HLA-DR2/3 in SLE, HLA-DR2 in Goodpasture's syndrome) were associated with significantly higher graft survival in certain patient groups and races. HLA-DR1 showed benefit in non-HLA-DR-associated diseases.
    • Black recipients under 50 had poorer outcomes than comparable Whites. Pre-transplant health status significantly influenced graft survival across all disease groups.

    Conclusions:

    • Racial background and specific HLA tissue types are critical determinants of kidney transplant success, necessitating tailored approaches in recipient selection and management.
    • The association between certain HLA-DR alleles and improved graft survival highlights the potential for immunogenetic matching to optimize transplant outcomes.
    • Addressing racial disparities, recipient health status, and age-related factors is essential for improving long-term kidney allograft function.